Workshop 2 - How can we use personalised medicine in primary care in the UK?

Talk Code: 

Facilitator: Robert Walton, Queen Mary University London Group facilitators and scribes will be selected in advance from those participating in the workshop to ensure a spread of interests and institutions. Pre workshop notes and a briefing document will be circulated. Background Simon Stevens, the new chief executive of NHS England used his maiden speech in June 2014 to highlight the ‘global medical revolution' caused by personalised medicine (1). Stevens wants the NHS to lead this revolution developing new diagnostic tools to target treatments more effectively to patients who will benefit most. But how well prepared is primary care for this new challenge and can we channel the forces for change to bring real benefits for our patients?Aim and intended outcome To identify

  • key clinical areas where advances in personalised or stratified medicine could improve the quality of primary health care in the UK
  • how change might be implemented in a challenging primary care environment.

Educational objectives Participants will gain understanding of

  • key principles underlying personalised and stratified medicine
  • potential benefits - increased effectiveness reduced side effects of therapies
  • ethical legal and social issues pertinent to these new developments
  • facilitators and barriers to implementation in UK primary care
  • implications for medical education - teaching and training

Intended audience Relevant to people interested in new developments in personalised medicine that are relevant to primary care in the UK.


  • Robert Walton